Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methimazole
Drug ID BADD_D01414
Description Methimazole is a thionamide antithyroid agent that inhibits the synthesis of thyroid hormones.[A184559,A184733,A184694] It was first introduced as an antithyroid agent in 1949[A184502] and is now commonly used in the management of hyperthyroidism, particularly in those for whom more aggressive options such as surgery or radioactive iodine therapy are inappropriate.[L8336,L8339] On a weight basis, methimazole is 10 times more potent than the other major antithyroid thionamide used in North America, [propylthiouracil],[L8339] and is the active metabolite of the pro-drug [carbimazole], which is an antithyroid medication used in the United Kingdom and parts of the former British Commonwealth.[A184733] Traditionally, methimazole has been preferentially used over propylthiouracil due to the risk of fulminant hepatotoxicity carried by the latter,[A184757] with propylthiouracil being preferred in pregnancy due to a perceived lower risk of teratogenic effects. Despite documented teratogenic effects in its published labels,[L8336,L8339] the true teratogenicity of methimazole appears to be unclear[A184643,A184757,A184763] and its place in therapy may change in the future.
Indications and Usage For the treatment of hyperthyroidism, goiter, Graves disease and psoriasis.
Marketing Status Prescription; Discontinued
ATC Code H03BB02
DrugBank ID DB00763
KEGG ID D00401
MeSH ID D008713
PubChem ID 1349907
TTD Drug ID D0S4BR
NDC Product Code 68071-5197; 38779-0360; 60429-380; 63629-2027; 63629-8347; 64980-260; 51927-1943; 71335-0883; 63629-9250; 63629-2026; 63629-9137; 50090-3334; 60687-357; 23155-070; 60429-381; 49884-640; 70518-1506; 63629-9251; 50090-2366; 51552-0822; 62991-1515; 70518-1475; 62135-206; 60687-370; 63629-2225; 66219-0253; 63629-9249; 0185-0205; 0185-0210; 54382-112; 23155-071; 63629-2224; 49884-641; 62135-205; 49452-4573; 64980-261; 63629-6408
Synonyms Methimazole | 1-Methyl-2-mercaptoimidazole | 1 Methyl 2 mercaptoimidazole | Merkazolil | Tiamazol | Thiamazole | Thimazol | Mercasolyl | Mercazolyl | Methymazol | Methylmercaptoimidazole | Mercazol | Mercazole | Metisol | Metizol | Tapazole | Tirodril | Strumazol | Thiamazol Henning | Henning, Thiamazol | Thiamazol Hexal | Hexal, Thiamazol | Thyrozol | Favistan | Methizol
Chemical Information
Molecular Formula C4H6N2S
CAS Registry Number 60-56-0
SMILES CN1C=CNC1=S
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Insulin autoimmune syndromeHLA class II histocompatibility antigen, DRB1 beta chainP01911Not Available8064238; 11751969; 7604034; 9119530; 15711804; 10233671; 7679413; 7519208; 11290778
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Tachycardia02.03.02.0070.002166%Not Available
Thrombocytopenia01.08.01.0020.002707%Not Available
Thyrotoxic crisis19.07.03.006; 06.09.04.004; 14.11.01.016; 05.02.02.0040.008121%Not Available
Tonsillar hypertrophy22.04.05.0060.001083%Not Available
Tremor17.01.06.002--
Urticaria23.04.02.001; 10.01.06.0010.002166%
Vertigo17.02.12.002; 04.04.01.003--
Vomiting07.01.07.003--
Abasia17.02.05.035; 08.01.02.0070.001083%Not Available
Lupus-like syndrome23.03.02.004; 15.06.02.004; 10.04.03.0030.001083%Not Available
Acute coronary syndrome24.04.04.011; 02.02.02.0150.001624%Not Available
Musculoskeletal discomfort15.03.04.001--Not Available
Pharyngeal erythema22.04.05.0100.001083%Not Available
Congenital eye disorder06.08.03.011; 03.01.01.0020.001083%Not Available
Blood alkaline phosphatase increased13.04.02.0040.001624%
Decreased appetite14.03.01.005; 08.01.09.028--
Salivary gland disorder07.06.02.001--Not Available
Pigmentation disorder23.05.03.001--Not Available
Bone marrow failure01.03.03.0050.002166%
Liver injury12.01.02.003; 09.01.07.0220.000282%Not Available
Low birth weight baby18.04.02.0030.001624%Not Available
Type 1 diabetes mellitus14.06.01.010; 10.04.08.007; 05.06.01.0100.001083%Not Available
Cholestatic liver injury09.01.07.0160.001083%Not Available
Oropharyngeal pain22.02.05.022; 07.05.05.0040.003790%
Mechanical urticaria23.04.02.004; 10.01.06.0040.001083%Not Available
Kounis syndrome24.04.04.020; 10.01.03.037; 02.02.02.0200.001083%Not Available
Acute kidney injury20.01.03.0160.001624%
Drug-induced liver injury12.03.01.044; 09.01.07.0230.003249%Not Available
Candida infection11.03.03.0210.001083%
Multiple organ dysfunction syndrome08.01.03.0570.000282%
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages